Logo image of ALS.CA

ALTIUS MINERALS CORPORATION (ALS.CA) Stock Fundamental Analysis

Canada - TSX:ALS - CA0209361009 - Common Stock

35.77 CAD
+0.29 (+0.82%)
Last: 10/23/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALS. ALS was compared to 805 industry peers in the Metals & Mining industry. While ALS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ALS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ALS had positive earnings in the past year.
In the past year ALS had a positive cash flow from operations.
ALS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years ALS had a positive operating cash flow.
ALS.CA Yearly Net Income VS EBIT VS OCF VS FCFALS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

ALS's Return On Assets of 13.83% is amongst the best of the industry. ALS outperforms 94.66% of its industry peers.
ALS has a better Return On Equity (17.37%) than 94.16% of its industry peers.
ALS's Return On Invested Capital of 1.84% is amongst the best of the industry. ALS outperforms 89.07% of its industry peers.
ALS had an Average Return On Invested Capital over the past 3 years of 3.48%. This is significantly below the industry average of 12.09%.
Industry RankSector Rank
ROA 13.83%
ROE 17.37%
ROIC 1.84%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ALS.CA Yearly ROA, ROE, ROICALS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With an excellent Profit Margin value of 210.11%, ALS belongs to the best of the industry, outperforming 99.38% of the companies in the same industry.
ALS's Profit Margin has improved in the last couple of years.
ALS's Operating Margin of 41.65% is amongst the best of the industry. ALS outperforms 97.64% of its industry peers.
ALS's Operating Margin has been stable in the last couple of years.
ALS has a better Gross Margin (88.04%) than 99.63% of its industry peers.
In the last couple of years the Gross Margin of ALS has remained more or less at the same level.
Industry RankSector Rank
OM 41.65%
PM (TTM) 210.11%
GM 88.04%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
ALS.CA Yearly Profit, Operating, Gross MarginsALS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

6

2. Health

2.1 Basic Checks

ALS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ALS has been reduced compared to 1 year ago.
Compared to 5 years ago, ALS has more shares outstanding
Compared to 1 year ago, ALS has a worse debt to assets ratio.
ALS.CA Yearly Shares OutstandingALS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALS.CA Yearly Total Debt VS Total AssetsALS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ALS has an Altman-Z score of 7.16. This indicates that ALS is financially healthy and has little risk of bankruptcy at the moment.
ALS has a better Altman-Z score (7.16) than 62.86% of its industry peers.
ALS has a debt to FCF ratio of 5.08. This is a neutral value as ALS would need 5.08 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.08, ALS belongs to the top of the industry, outperforming 90.93% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that ALS is not too dependend on debt financing.
ALS has a worse Debt to Equity ratio (0.16) than 66.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 5.08
Altman-Z 7.16
ROIC/WACC0.22
WACC8.17%
ALS.CA Yearly LT Debt VS Equity VS FCFALS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 2.35 indicates that ALS has no problem at all paying its short term obligations.
ALS has a Current ratio of 2.35. This is comparable to the rest of the industry: ALS outperforms 55.16% of its industry peers.
ALS has a Quick Ratio of 2.35. This indicates that ALS is financially healthy and has no problem in meeting its short term obligations.
ALS has a Quick ratio (2.35) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
ALS.CA Yearly Current Assets VS Current LiabilitesALS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

3

3. Growth

3.1 Past

ALS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.63%.
ALS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.58% yearly.
Looking at the last year, ALS shows a very negative growth in Revenue. The Revenue has decreased by -24.35% in the last year.
Measured over the past years, ALS shows a decrease in Revenue. The Revenue has been decreasing by -1.01% on average per year.
EPS 1Y (TTM)-29.63%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-24.35%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-49.66%

3.2 Future

Based on estimates for the next years, ALS will show a very strong growth in Earnings Per Share. The EPS will grow by 24.80% on average per year.
Based on estimates for the next years, ALS will show a small growth in Revenue. The Revenue will grow by 7.95% on average per year.
EPS Next Y2.25%
EPS Next 2Y32.8%
EPS Next 3Y33.08%
EPS Next 5Y24.8%
Revenue Next Year-14.54%
Revenue Next 2Y1.71%
Revenue Next 3Y1.28%
Revenue Next 5Y7.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALS.CA Yearly Revenue VS EstimatesALS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
ALS.CA Yearly EPS VS EstimatesALS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

ALS is valuated quite expensively with a Price/Earnings ratio of 188.26.
85.34% of the companies in the same industry are more expensive than ALS, based on the Price/Earnings ratio.
ALS is valuated expensively when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 75.12, which means the current valuation is very expensive for ALS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALS indicates a rather cheap valuation: ALS is cheaper than 86.21% of the companies listed in the same industry.
ALS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.33.
Industry RankSector Rank
PE 188.26
Fwd PE 75.12
ALS.CA Price Earnings VS Forward Price EarningsALS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALS indicates a rather cheap valuation: ALS is cheaper than 88.45% of the companies listed in the same industry.
90.43% of the companies in the same industry are more expensive than ALS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 83.01
EV/EBITDA 69.08
ALS.CA Per share dataALS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALS does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ALS may justify a higher PE ratio.
A more expensive valuation may be justified as ALS's earnings are expected to grow with 33.08% in the coming years.
PEG (NY)83.83
PEG (5Y)N/A
EPS Next 2Y32.8%
EPS Next 3Y33.08%

6

5. Dividend

5.1 Amount

ALS has a Yearly Dividend Yield of 1.13%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 12.79, ALS pays a better dividend. On top of this ALS pays more dividend than 97.27% of the companies listed in the same industry.
With a Dividend Yield of 1.13, ALS pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.13%

5.2 History

The dividend of ALS has a limited annual growth rate of 0.59%.
ALS has been paying a dividend for at least 10 years, so it has a reliable track record.
ALS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.59%
Div Incr Years4
Div Non Decr Years4
ALS.CA Yearly Dividends per shareALS.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

ALS pays out 15.18% of its income as dividend. This is a sustainable payout ratio.
The dividend of ALS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP15.18%
EPS Next 2Y32.8%
EPS Next 3Y33.08%
ALS.CA Yearly Income VS Free CF VS DividendALS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
ALS.CA Dividend Payout.ALS.CA Dividend Payout, showing the Payout Ratio.ALS.CA Dividend Payout.PayoutRetained Earnings

ALTIUS MINERALS CORPORATION

TSX:ALS (10/23/2025, 7:00:00 PM)

35.77

+0.29 (+0.82%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-11 2025-11-11
Inst Owners20.1%
Inst Owner ChangeN/A
Ins Owners5.34%
Ins Owner ChangeN/A
Market Cap1.65B
Revenue(TTM)47.19M
Net Income(TTM)99.15M
Analysts78.18
Price Target36.65 (2.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.13%
Yearly Dividend0.32
Dividend Growth(5Y)0.59%
DP15.18%
Div Incr Years4
Div Non Decr Years4
Ex-Date08-29 2025-08-29 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.51%
Min EPS beat(2)-29.28%
Max EPS beat(2)-25.74%
EPS beat(4)1
Avg EPS beat(4)-16.37%
Min EPS beat(4)-29.28%
Max EPS beat(4)18.81%
EPS beat(8)2
Avg EPS beat(8)-16.05%
EPS beat(12)2
Avg EPS beat(12)-23.29%
EPS beat(16)3
Avg EPS beat(16)-14.98%
Revenue beat(2)0
Avg Revenue beat(2)-14.07%
Min Revenue beat(2)-22.8%
Max Revenue beat(2)-5.33%
Revenue beat(4)0
Avg Revenue beat(4)-13.87%
Min Revenue beat(4)-22.8%
Max Revenue beat(4)-5.33%
Revenue beat(8)2
Avg Revenue beat(8)-10.26%
Revenue beat(12)3
Avg Revenue beat(12)-7.39%
Revenue beat(16)5
Avg Revenue beat(16)-5.31%
PT rev (1m)0.6%
PT rev (3m)6.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.01%
Valuation
Industry RankSector Rank
PE 188.26
Fwd PE 75.12
P/S 35.07
P/FCF 83.01
P/OCF 74.96
P/B 2.9
P/tB 2.9
EV/EBITDA 69.08
EPS(TTM)0.19
EY0.53%
EPS(NY)0.48
Fwd EY1.33%
FCF(TTM)0.43
FCFY1.2%
OCF(TTM)0.48
OCFY1.33%
SpS1.02
BVpS12.34
TBVpS12.34
PEG (NY)83.83
PEG (5Y)N/A
Graham Number7.26
Profitability
Industry RankSector Rank
ROA 13.83%
ROE 17.37%
ROCE 2.78%
ROIC 1.84%
ROICexc 1.87%
ROICexgc 1.87%
OM 41.65%
PM (TTM) 210.11%
GM 88.04%
FCFM 42.24%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ROICexc(3y)3.89%
ROICexc(5y)3.81%
ROICexgc(3y)3.89%
ROICexgc(5y)3.82%
ROCE(3y)5.26%
ROCE(5y)5.17%
ROICexgc growth 3Y-14.71%
ROICexgc growth 5Y-5.44%
ROICexc growth 3Y-14.71%
ROICexc growth 5Y-5.14%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 5.08
Debt/EBITDA 3.69
Cap/Depr 38.31%
Cap/Sales 4.54%
Interest Coverage 2.43
Cash Conversion 87.43%
Profit Quality 20.1%
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 7.16
F-Score5
WACC8.17%
ROIC/WACC0.22
Cap/Depr(3y)21.45%
Cap/Depr(5y)17.13%
Cap/Sales(3y)3.12%
Cap/Sales(5y)3.13%
Profit Quality(3y)194.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.63%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-66.67%
EPS Next Y2.25%
EPS Next 2Y32.8%
EPS Next 3Y33.08%
EPS Next 5Y24.8%
Revenue 1Y (TTM)-24.35%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-49.66%
Revenue Next Year-14.54%
Revenue Next 2Y1.71%
Revenue Next 3Y1.28%
Revenue Next 5Y7.95%
EBIT growth 1Y-34.28%
EBIT growth 3Y-10.93%
EBIT growth 5Y0.32%
EBIT Next Year46.36%
EBIT Next 3Y28.27%
EBIT Next 5Y19.11%
FCF growth 1Y-67.12%
FCF growth 3Y-18.25%
FCF growth 5Y17.22%
OCF growth 1Y-64.63%
OCF growth 3Y-16.08%
OCF growth 5Y0.4%